Use of anthrax vaccine in the United States: Recommendations of the advisory committee on immunization practices

Journal of Toxicology - Clinical Toxicology

Volumn 39, Issue 1, 2001, Pages 85-100

  Modlin, J F ^a   Snider D E , Jr ^a   Brooks, D A ^a   Clover, R D ^a   Guerra, F A ^a   Helms, C M ^a   Johnson, D R ^a   Le, C T ^a   Offit, P A ^a   Rennels, M B ^a   Tompkins, L S ^a   Word, B M ^a   Bradshaw, D ^a   Cheek, J E ^a   Evans, G S ^a   Graydon, T R ^a   Myers, M G ^a,a   Heilman, C ^a   Midthun, K ^a   Nichol, K L ^a   Mahoney, M ^a   Pickering, L ^a   Abramson, J ^a   France, E K ^a   Gall, S A ^a   Gardner, P ^a   Schaffner, W ^a   Wilson, H D ^a   McKinney, W P ^a   Marchessault, V ^a   Siegel, J D ^a   Katz, S L ^a   Santos, J I ^a   Jackson, R E ^a   Peter, G ^a   Howe, B J ^a   Ashford, D A ^a   Rotz, L D ^a   more..

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM POTASSIUM SULFATE; AMOXICILLIN; ANTHRAX VACCINE; ANTIBODY; AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; EXOTOXIN; OFLOXACIN; PENICILLIN V; POLYCLONAL ANTIBODY; PROTEIN;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CHILL; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEVER; HUMAN; IMMUNITY; IMMUNIZATION; INCIDENCE; INFECTION CONTROL; NAUSEA; NONHUMAN; PAIN; PATHOGENESIS; SUBCUTANEOUS NODULE; SYMPTOMATOLOGY; UNITED STATES;

ADULT; ANIMALS; ANTHRAX; ANTHRAX VACCINES; BACILLUS ANTHRACIS; CHILD; HUMANS; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; UNITED STATES;

ANTHRAX; BACILLUS ANTHRACIS;

EID: 0035055387     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102886     Document Type: Article

References (87)

1. Anthrax
2. The Aetiology of Anthrax Based on the Ontogeny of the Anthrax Bacillus
3. On Anthrax and Athracaemia in Wool Sorters, Heifers, and Sheep
4. A Major Epidemic of Anthrax in Zimbabwe
5. Ecology of Anthrax
6. Inhalation Anthrax
7. Anthrax
8. Incidence of Anthrax in the USA: 1945-1988
9. Surveillance for Adverse Events Associated with Anthrax Vaccination - US Department of Defense, 1998-2000
10. Anthrax as a Potential Biological Warfare Agent
11. Anthrax as a Biological Weapon
12. Biological Warfare: A Historical Perspective
13. Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents
14. Experimental Inhalation Anthrax in the Chimpanzee
15. Familial Occurrence of Anthrax in Eastern Algeria
16. Anthrax
17. Acute Abdomen Due to Anthrax
18. Intestinal Anthrax in Man: A Case Report
19. An Outbreak of Human Gastrointestinal Anthrax
20. The Sverdlovsk Anthrax Outbreak of 1979
21. An Epidemic of Inhalation Anthrax: The First in the Twentieth Century. II. Epidemiology
22. Observations on the Prophylaxis of Experimental Pulmonary Anthrax in the Monkey
23. Pathology of Experimental Respiratory Anthrax in Macaca mulatta
24. Anthrax: The Disease in Relation to Vaccines
25. Anthrax
26. Evidence for Plasmid-Mediated Toxin Production in Bacillus anthracis
27. Anthrax Toxin
28. Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
29. Anthrax: Virulence and Vaccines
30. Bioterrorism: Microbiology Key to Dealing with Threats
31. Anthrax Protective Antigen Forms Oligomers During Intoxication of Mammalian Cells
32. How Anthrax Kills
33. On the Attenuation of Viruses and on it's Return to Virulence [French]
34. Lectures on Some Recent Investigations into the Pathology of Infective and Contagious Diseases. Lecture III; Part I. Anthrax and Anthracoid Diseases
35. The Use of Anthrax Vaccines Prepared from Avirulent (Unencapsulated) Variants of Bacillus anthracis, Onderstepoort
36. The Immunization of Laboratory Animals Against Anthrax
37. Research into Natural and Artificial Anthrax Immunity [German]
38. Anthrax Aggressin
39. Immunity to Anthrax: Protective Antigen Present in Cell-Free Culture Filtrates
40. Studies on a Protective Antigen Produced in Vitro from Bacillus anthracis: Medium and Methods of Production
41. Immunologic Studies of Anthrax: IV. Evaluation of the Immunogenicity of Three Components of Anthrax Toxin
42. Large-Scale Production of Protective Antigen of Bacillus anthracis in Aerobic Cultures
43. Studies on Immunity in Anthrax. X. Gel-Adsorbed Protective Antigen for Immunization in Man
44. Studies on Immunity in Anthrax. V. Immunizing Activity of Alum-Precipitated Protective Antigen
45. An Antigen Prepared in Vitro Effective for Immunization Against Anthrax. III. Immunization of Monkeys Against Anthrax
46. Passive Protection by Polyclonal Antibodies Against Bacillus anthracis Infection in Guinea Pigs
47. In vitro Correlate of Immunity in an Animal Model of Inhalational Anthrax
48. Immune Correlates of Protection Against Anthrax
49. Development of Antibodies to Protective Antigen and Lethal Factor Components of Anthrax Toxin in Humans and Guinea Pigs and Their Relevance to Protective Immunity
50. Rapid Lethal Effect in Rats of a Third Component Found Upon Fractionating the Toxin Bacillus anthracis
51. Veterinary Laboratory Investigation Center Abshire, T.G. Kidd, S. Kaufmann, A.F. Evaluation of Serologic Tests for Diagnosis of Anthrax After an Outbreak of Cutaneous Anthrax in Paraguay
52. Adult Immunization
53. The Use of Anthrax Antigen to Immunise Man and Monkey
54. Anthrax Vaccines: Past, Present and Future
55. Field Evaluation of a Human Anthrax Vaccine
56. Comparison of Enzyme-Linked Immunosorbent and Indirect Hemagglutination Assays for Determining Anthrax Antibodies
57. Immunization Studies with Attenuated Strains of Bacillus anthracis
58. Studies on Immunity in Anthrax. VI. Immunizing Activity of Protective Antigen Against Various Strains of Bacillus anthracis
59. Comparative Efficacy of Bacillus anthracis Live Spore Vaccine and Protective Antigen Vaccine Against Anthrax in the Guinea Pig
60. Studies on Anthrax Infections in Immunized Guinea Pigs
61. Efficacy of a Standard Human Anthrax Vaccine Against Bacillus anthracis Aerosol Spore Challenge in Rhesus Monkeys
62. Comparison of the Efficacy of Purified Protective Antigen and MDPH [AVA] to Protect Nonhuman Primates from Inhalation Anthrax
63. Comparative Efficacy of Experimental Anthrax Vaccine Candidates Against Inhalation Anthrax in Rhesus Macaques
64. Anthrax Vaccine: Evidence for Safety and Efficacy Against Inhalational Anthrax
65. The Vaccine Adverse Event Reporting System (VAERS)
66. Committee on Health Effects Associated with Exposures During the Gulf War, Institute of Medicine
67. Intensive Immunization of Man: Evaluation of Possible Adverse Consequences
68. Repeated Immunization: Possible Adverse Effects - Reevaluation of Human Subjects at 25 Years
69. Chronic Multisymptom Illness Affecting Air Force Veterans of the Gulf War
70. Self-Reported Illness and Health Status Among Gulf War Veterans: A Population-Based Study
71. Bioterrorism Alleging Use of Anthrax and Interim Guidelines for Management - United States, 1998
72. Penicillin and B. anthracis
73. Antimicrobial Susceptibility of Bacillus anthracis
74. Antimicrobial Susceptibility of Bacillus anthracis
75. Postexposure Prophylaxis Against Experimental Inhalation Anthrax